Merck wins approval for glaucoma treatment
Merck has been cleared by the Food and Drug Administration to market Zioptan 0.0015%, which the company said is the first preservative-free prostaglandin analog ophthalmic solution. The pharmaceutical company said Monday that Zioptan (tafluprost ophthalmic solution 0.